[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-ablynx":3,"geo-ablynx":-1,"alternatives-ablynx":23},{"id":4,"slug":5,"name":6,"wikidata_qid":7,"gleif_lei":8,"isin":9,"ultimate_parent_id":9,"hq_country_code":10,"hq_city":11,"founded_year":12,"official_website":13,"manufacturing_countries":9,"logo_url":9,"description":14,"is_eu_headquartered":15,"is_eu_manufactured":15,"eu_score_label":16,"attributes":17,"data_quality":18,"enriched_at":19,"created_at":20,"updated_at":21,"ownership_type":9,"stock_exchange":9,"tax_domicile":9,"ultimate_parent_name":9,"ultimate_parent_country":9,"data_hosting_country":9,"cloud_act_exposure":9,"ai_training_on_user_data":9,"dsa_designation":9,"gdpr_fines_total_eur":9,"gdpr_compliance_status":9,"supply_chain_transparency":9,"sustainable_materials":9,"carbon_neutral":9,"repair_recycling_program":9,"pays_eu_taxes":9,"eu_regulatory_fines":9,"b_corp_certified":9,"ethical_certifications":9,"ownership_disclosed":9,"annual_report_published":9,"supply_chain_audit_published":9,"timeline_events":9,"extended_enriched_at":9,"category_primary_id":9,"category_secondary_id":9,"category_confidence":22},"5c6fde23-40e1-4ade-b848-59edb01b888e","ablynx","Ablynx","Q4668104","549300ZL08QVVII6W560",null,"BE","Ghent",2001,"http:\u002F\u002Fwww.ablynx.com\u002F","Ablynx is a biopharmaceutical company specializing in the development of Nanobody-based therapeutic proteins for a range of human diseases. The company was founded in 2001 and currently operates as a subsidiary of the French multinational pharmaceutical company Sanofi.",true,"eu_hq_and_owned",{},"complete","2026-07-19T18:27:37.485+00:00","2026-07-09T06:21:59.876343+00:00","2026-07-22T17:08:59.998378+00:00",0,[]]